Mr. Chopra serves as the Corporate Vice President of Transcatheter Mitral and Tricuspid Therapies at Edwards Lifesciences Corp, a leading innovator in the field of structural heart disease. With a robust background in medical device development and commercialization, Mr. Chopra has been instrumental in advancing Edwards Lifesciences' mission to transform patient care through innovative therapies. He joined the company with a wealth of experience in the cardiovascular sector, having held key leadership positions at several prominent medical device firms prior to his current role. In his capacity at Edwards Lifesciences, Mr. Chopra oversees the strategic direction and development of transcatheter therapies for mitral and tricuspid valve diseases. His leadership has been pivotal in driving the research, development, and clinical adoption of these life-changing technologies. Under his guidance, the company has made significant strides in expanding its portfolio of minimally invasive solutions, aiming to improve patient outcomes and quality of life. Mr. Chopra's commitment to innovation and excellence is evident in the successful launch and ongoing support of multiple transcatheter valve systems, which have garnered recognition for their clinical efficacy and transformative impact on patient care. Before joining Edwards Lifesciences, Mr. Chopra held various executive roles where he demonstrated a keen ability to navigate complex regulatory environments and foster collaboration across multidisciplinary teams. His strategic vision and operational expertise have earned him a reputation as a thought leader in the medical device industry. Mr. Chopra's dedication to advancing healthcare solutions continues to drive Edwards Lifesciences forward, positioning the company at the forefront of transcatheter valve therapies and reinforcing its commitment to improving the lives of patients worldwide.